Learn about research studies and clinical trials conducted by the Division of Infectious Disease in the area of COVID-19.
- Lindsey Baden, MD: COVID-19 vaccines
- Ingrid Bassett, MD, MPH: Developing observational MGH COVID-19 registry to evaluate risk factors and clinical outcomes
- Roby P. Bhattacharyya, MD, PhD: Single-cell immune profiling in COVID-19; serological assay development and evaluation in at-risk populations
- Andrea Ciaranello, MD: Clinical outcomes, epidemiology, and simulation modeling in the United States and resource-limited settings
- Marcia B. Goldberg, MD: High resolution analysis of immune responses to COVID-19
- Yonatan Grad, MD, PhD: COVID-19 epidemiology and the impact of interventions to slow and control spread
- Arthur Kim, MD: Clinical (hospitalized patients) and translational (immunology) research in COVID-19
- Camille Nelson Kotton, MD: Epidemiology of COVID-19 and immunocompromised hosts; impact of zanubrutinib on pulmonary distress in COVID-19
- Jonathan Li, MD: SARS-CoV-2 pathogenesis, sequence analysis, and treatment trials
- Mark Poznansky, MD, PhD: Defining protective immunity to SARS-CoV-2 to inform the development of a safe and effective vaccine
- Edward Ryan, MD, DTM&H: Host-pathogen interactions, immune responses, and vaccine development for bacterial pathogens and COVID-19
- Erica Shenoy, MD, PhD: COVID-19 epidemiology, including nosocomial infection, healthcare worker infection, and levering informatics for infection prevention/control
- Mark Siedner, MD: COVID-19 surveillance in rural South Africa and impacts of control measures on older Ugandans
- Jatin Vyas, MD, PhD: Clinical significance of viral shedding from asymptomatic patients